ID ICMT_HUMAN Reviewed; 284 AA. AC O60725; Q6FHT0; DT 20-JUN-2001, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1998, sequence version 1. DT 27-MAR-2024, entry version 181. DE RecName: Full=Protein-S-isoprenylcysteine O-methyltransferase; DE EC=2.1.1.100 {ECO:0000269|PubMed:9614111}; DE AltName: Full=Isoprenylcysteine carboxylmethyltransferase; DE AltName: Full=Prenylated protein carboxyl methyltransferase; DE Short=PPMT; DE AltName: Full=Prenylcysteine carboxyl methyltransferase; DE Short=pcCMT; GN Name=ICMT; Synonyms=PCCMT; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, ACTIVITY RP REGULATION, AND SUBCELLULAR LOCATION. RC TISSUE=Myeloid; RX PubMed=9614111; DOI=10.1074/jbc.273.24.15030; RA Dai Q., Choy E., Chiu V., Romano J., Slivka S.R., Steitz S.A., RA Michaelis S., Philips M.R.; RT "Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic RT reticulum."; RL J. Biol. Chem. 273:15030-15034(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP TISSUE SPECIFICITY. RX PubMed=10649571; DOI=10.1038/72101; RA Lin X., Antalffy B., Kang D., Orr H.T., Zoghbi H.Y.; RT "Polyglutamine expansion down-regulates specific neuronal genes before RT pathologic changes in SCA1."; RL Nat. Neurosci. 3:157-163(2000). RN [7] RP SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY. RX PubMed=19158273; DOI=10.1128/mcb.01719-08; RA Wright L.P., Court H., Mor A., Ahearn I.M., Casey P.J., Philips M.R.; RT "Topology of mammalian isoprenylcysteine carboxyl methyltransferase RT determined in live cells with a fluorescent probe."; RL Mol. Cell. Biol. 29:1826-1833(2009). CC -!- FUNCTION: Catalyzes the post-translational methylation of isoprenylated CC C-terminal cysteine residues. {ECO:0000269|PubMed:9614111}. CC -!- CATALYTIC ACTIVITY: CC Reaction=[protein]-C-terminal S-[(2E,6E)-farnesyl]-L-cysteine + S- CC adenosyl-L-methionine = [protein]-C-terminal S-[(2E,6E)-farnesyl]-L- CC cysteine methyl ester + S-adenosyl-L-homocysteine; CC Xref=Rhea:RHEA:21672, Rhea:RHEA-COMP:12125, Rhea:RHEA-COMP:12126, CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:90510, CC ChEBI:CHEBI:90511; EC=2.1.1.100; CC Evidence={ECO:0000269|PubMed:9614111}; CC -!- ACTIVITY REGULATION: Competitively inhibited by N-acetyl-S-trans,trans- CC farnesyl-l-cysteine (AFC). {ECO:0000269|PubMed:9614111}. CC -!- INTERACTION: CC O60725; Q13520: AQP6; NbExp=3; IntAct=EBI-11721771, EBI-13059134; CC O60725; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-11721771, EBI-11343438; CC O60725; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-11721771, EBI-10266796; CC O60725; P48051: KCNJ6; NbExp=3; IntAct=EBI-11721771, EBI-12017638; CC O60725; P15941-11: MUC1; NbExp=3; IntAct=EBI-11721771, EBI-17263240; CC O60725; Q13113: PDZK1IP1; NbExp=3; IntAct=EBI-11721771, EBI-716063; CC O60725; Q6ZMZ0: RNF19B; NbExp=3; IntAct=EBI-11721771, EBI-2466594; CC O60725; Q13049: TRIM32; NbExp=3; IntAct=EBI-11721771, EBI-742790; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:19158273, ECO:0000269|PubMed:9614111}; Multi-pass CC membrane protein {ECO:0000269|PubMed:19158273}. CC -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at higher levels CC in the cerebellum and putamen than in other brain regions. Abundant CC expression seen in the Purkinje cells and pontine neurons. CC {ECO:0000269|PubMed:10649571}. CC -!- SIMILARITY: Belongs to the class VI-like SAM-binding methyltransferase CC superfamily. Isoprenylcysteine carboxyl methyltransferase family. CC {ECO:0000255|PROSITE-ProRule:PRU00897}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF064084; AAC16554.1; -; mRNA. DR EMBL; CR541671; CAG46472.1; -; mRNA. DR EMBL; CR541711; CAG46512.1; -; mRNA. DR EMBL; AL031847; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471130; EAW71522.1; -; Genomic_DNA. DR EMBL; BC028168; AAH28168.1; -; mRNA. DR CCDS; CCDS61.1; -. DR RefSeq; NP_036537.1; NM_012405.3. DR AlphaFoldDB; O60725; -. DR SMR; O60725; -. DR BioGRID; 117026; 134. DR IntAct; O60725; 25. DR MINT; O60725; -. DR STRING; 9606.ENSP00000343552; -. DR BindingDB; O60725; -. DR ChEMBL; CHEMBL4699; -. DR iPTMnet; O60725; -. DR PhosphoSitePlus; O60725; -. DR SwissPalm; O60725; -. DR BioMuta; ICMT; -. DR EPD; O60725; -. DR jPOST; O60725; -. DR MassIVE; O60725; -. DR PaxDb; 9606-ENSP00000343552; -. DR PeptideAtlas; O60725; -. DR ProteomicsDB; 49571; -. DR Pumba; O60725; -. DR Antibodypedia; 27272; 213 antibodies from 26 providers. DR DNASU; 23463; -. DR Ensembl; ENST00000343813.10; ENSP00000343552.5; ENSG00000116237.16. DR GeneID; 23463; -. DR KEGG; hsa:23463; -. DR MANE-Select; ENST00000343813.10; ENSP00000343552.5; NM_012405.4; NP_036537.1. DR UCSC; uc001amk.4; human. DR AGR; HGNC:5350; -. DR CTD; 23463; -. DR DisGeNET; 23463; -. DR GeneCards; ICMT; -. DR HGNC; HGNC:5350; ICMT. DR HPA; ENSG00000116237; Low tissue specificity. DR MIM; 605851; gene. DR neXtProt; NX_O60725; -. DR OpenTargets; ENSG00000116237; -. DR PharmGKB; PA29598; -. DR VEuPathDB; HostDB:ENSG00000116237; -. DR eggNOG; KOG2628; Eukaryota. DR GeneTree; ENSGT00390000017394; -. DR HOGENOM; CLU_065200_0_1_1; -. DR InParanoid; O60725; -. DR OMA; YFGWFWR; -. DR OrthoDB; 5473160at2759; -. DR PhylomeDB; O60725; -. DR TreeFam; TF313769; -. DR BRENDA; 2.1.1.100; 2681. DR PathwayCommons; O60725; -. DR Reactome; R-HSA-163841; Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation. DR Reactome; R-HSA-9648002; RAS processing. DR SABIO-RK; O60725; -. DR SignaLink; O60725; -. DR BioGRID-ORCS; 23463; 80 hits in 1166 CRISPR screens. DR ChiTaRS; ICMT; human. DR GeneWiki; ICMT; -. DR GenomeRNAi; 23463; -. DR Pharos; O60725; Tchem. DR PRO; PR:O60725; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; O60725; Protein. DR Bgee; ENSG00000116237; Expressed in diaphragm and 213 other cell types or tissues. DR ExpressionAtlas; O60725; baseline and differential. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI. DR GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0016020; C:membrane; TAS:ProtInc. DR GO; GO:0003880; F:protein C-terminal carboxyl O-methyltransferase activity; TAS:ProtInc. DR GO; GO:0004671; F:protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity; IDA:FlyBase. DR GO; GO:0006481; P:C-terminal protein methylation; TAS:ProtInc. DR GO; GO:0036211; P:protein modification process; TAS:ProtInc. DR GO; GO:0006612; P:protein targeting to membrane; TAS:ProtInc. DR GO; GO:0046498; P:S-adenosylhomocysteine metabolic process; IEA:Ensembl. DR GO; GO:0046499; P:S-adenosylmethioninamine metabolic process; IEA:Ensembl. DR Gene3D; 1.20.120.1630; -; 1. DR InterPro; IPR007269; ICMT_MeTrfase. DR InterPro; IPR025770; PPMT_MeTrfase. DR PANTHER; PTHR12714; PROTEIN-S ISOPRENYLCYSTEINE O-METHYLTRANSFERASE; 1. DR PANTHER; PTHR12714:SF9; PROTEIN-S-ISOPRENYLCYSTEINE O-METHYLTRANSFERASE; 1. DR Pfam; PF04140; ICMT; 1. DR PROSITE; PS51564; SAM_ICMT; 1. DR Genevisible; O60725; HS. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Membrane; Methyltransferase; Reference proteome; KW S-adenosyl-L-methionine; Transferase; Transmembrane; Transmembrane helix. FT CHAIN 1..284 FT /note="Protein-S-isoprenylcysteine O-methyltransferase" FT /id="PRO_0000209894" FT TOPO_DOM 1..16 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 17..33 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 34..41 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 42..59 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 60..69 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 70..87 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 88..92 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 93..112 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 113..131 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 132..149 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 150..154 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 155..174 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 175..212 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 213..228 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 229 FT /note="Lumenal" FT /evidence="ECO:0000255" FT TRANSMEM 230..244 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 245..284 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT BINDING 190 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" FT BINDING 197..200 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" FT BINDING 205 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" FT BINDING 210..213 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" FT BINDING 247 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" FT BINDING 251 FT /ligand="S-adenosyl-L-methionine" FT /ligand_id="ChEBI:CHEBI:59789" FT /evidence="ECO:0000250|UniProtKB:D6WJ77" SQ SEQUENCE 284 AA; 31938 MW; C86741B13ACA611C CRC64; MAGCAARAPP GSEARLSLAT FLLGASVLAL PLLTRAGLQG RTGLALYVAG LNALLLLLYR PPRYQIAIRA CFLGFVFGCG TLLSFSQSSW SHFGWYMCSL SLFHYSEYLV TAVNNPKSLS LDSFLLNHSL EYTVAALSSW LEFTLENIFW PELKQITWLS VTGLLMVVFG ECLRKAAMFT AGSNFNHVVQ NEKSDTHTLV TSGVYAWFRH PSYVGWFYWS IGTQVMLCNP ICGVSYALTV WRFFRDRTEE EEISLIHFFG EEYLEYKKRV PTGLPFIKGV KVDL //